IHE

Equity ETFs

Finding Pharmaceuticals ETFs With Rebound Potential

By Tom LydonMay 4, 2016

Equity ETFs

17 Healthcare ETFs Investors Should Check Up On

By Tom LydonApril 28, 2016

Featured

Major Pharma Merger Boosts ETFs

By Tom LydonOctober 29, 2015

Featured

ETFs to Capitalize Off Obamacare Fueled Growth

By Tom LydonJuly 29, 2015

Featured

M&A Activity Will Support Pharma ETFs Through Rising Rate Environment

By Tom LydonJuly 9, 2015

Featured

Healthcare ETFs: Specialized Drugs in Greater Demand

By Tom LydonJuly 7, 2015

Featured

Investors Can Still Find Growth in Healthcare ETFs

By Tom LydonJuly 1, 2015

Featured

Healthcare ETFs can Work Even When Interest Rates Rise

By Todd ShriberJune 30, 2015

Featured

Innovators to Support Healthcare Sector, ETFs’ Growth

By Tom LydonMay 20, 2015

Equity ETFs

Pharma ETFs Boosted by Mylan’s Giant Offer for Perrigo

By Todd ShriberApril 8, 2015

Featured

Some ETFs Saying a Salix Takeover Could be Afoot

By Todd ShriberOctober 3, 2014

Featured

Pfizer, Actavis Rumor, Inversion Turn Attention to Pharma ETFs

By Tom LydonSeptember 24, 2014

Featured

iShares Announces Modest Fee Cuts on 24 ETFs

By Tom LydonSeptember 3, 2014

Featured

ETFs for Hedge Funds’ Favorite Pharma Stocks

By Tom LydonAugust 25, 2014

Featured

Investors Flee Once Hot Health Care ETFs

By Todd ShriberApril 28, 2014

Featured

Bill Ackman Might Like These Pharma ETFs

By Todd ShriberApril 22, 2014

Featured

Deal for Forest Fantastic for Pharma ETFs

By Todd ShriberFebruary 18, 2014

Featured

Fun With Pharma ETFs

By Todd ShriberJanuary 21, 2014